SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is buzzing with its community emphasizing a strong "culture" and long-term vision, as anticipation builds for the upcoming 4/20 event and the broader movement to deschedule cannabis. The crypto is positioned as "Bitcoin but way higher," fostering discussions on its potential for decentralized payments within the evolving cannabis industry.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as the community eagerly anticipates CEO Dr. Patrick Soon-Shiong's upcoming high-profile media appearances and an imminent investor conference call, fueling discussions about potential regulatory advancements for Anktiva, significant international partnerships, and the possibility of a short squeeze against perceived market manipulation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as the community debates its Q4 earnings results and anticipates new data on its HAE pipeline, particularly navenibart, at upcoming healthcare conferences; high short interest and institutional activity are amplifying discussions around a potential short squeeze and the company's long-term value.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as its offer for Warner Bros. Discovery was deemed superior, leading Netflix to withdraw its competing bid. The community is buzzing with excitement over the formation of a potential new media powerhouse with an expansive content and sports library, while also debating the strategic implications of the significant debt involved.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is seeing increased attention amid escalating geopolitical tensions involving Iran, with the community actively debating the potential for military action to impact oil prices. This speculation, combined with recent debt reduction and a favorable technical setup, is fueling discussions around a potential short squeeze in the oil and gas sector.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending following its Q4 earnings, which showed a profit beat and dividend hike powered by strong investment banking and trading, despite a revenue miss attributed to its Apple Card divestment. The community is actively debating if its leadership confirms a strengthening financial sector amid evolving market conditions.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is seeing intense debate as its PDUFA for a dry eye treatment was extended to March 16, 2026, following an FDA request for data from a trial that missed its primary endpoint, leading bulls to cite a draft label and CEO confidence while bears emphasize past rejections, cash runway concerns, and a key executive's departure.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is under intense scrutiny after voluntarily pausing its Phase 3 ARD-101 trial for Prader-Willi syndrome following reversible cardiac signals at high doses, prompting significant bearish sentiment and community questions about the therapy's future and management's past decisions.

Hawaiian Electric Industries, Inc. is a holding company, which engages in electric utility and non-regulated renewable and sustainable infrastructure businesses. The company was founded by C. Dudley Pratt Jr. in 1981 and is headquartered in Honolulu, HI.

Hawaiian Electric Industries, Inc.

Hawaiian Electric Industries is trending due to its significantly improved Q4 2025 earnings and key legislative actions that mitigate future wildfire liability risks, signaling a path towards financial recovery. The community is actively discussing these positive developments, with many investors anticipating long-term growth and potential dividend reinstatement, further bolstered by substantial institutional accumulation.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a massive surge following a significant earnings beat and upbeat guidance, fueled by robust demand for its 800G transceivers in AI data centers. This parabolic rally has ignited fervent community debate regarding its current extreme valuation and the potential impact of a recent at-the-market offering, amid broader sector enthusiasm for photonics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Princeton Bancorp (NASDAQ:BPRN) Trading 0.5% Higher - Here's What Happened

Princeton Bancorp (NASDAQ:BPRN) Shares Up 0.5% - Time to Buy...

Princeton Bancorp (NASDAQ:BPRN) Downgraded to "Strong Sell" Rating by Zacks Research

Zacks Research lowered Princeton Bancorp from a "hold" rating to a "strong sell" rating in a report on Tuesday...

Princeton Bancorp (NASDAQ:BPRN) Price Target Raised to $37.50

Hovde Group upped their target price on shares of Princeton Bancorp from $35.00 to $37.50 and gave the stock a "market perform" rating in a report on Tuesday...

Princeton Bancorp (BPRN) Q4 Earnings and Revenues Miss Estimates

Princeton Bancorp (BPRN) delivered earnings and revenue surprises of -3.74% and -6.75%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Princeton Bancorp (NASDAQ:BPRN) Issues Earnings Results

Princeton Bancorp (NASDAQ:BPRN - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate...

Princeton Bancorp Announces YTD & Fourth Quarter 2025 Results

Princeton Bancorp, Inc. (the Company) (NASDAQ - BPRN), the bank holding company for The Bank of Princeton (the Bank), today reported its unaudited financial condition at, and its results of...

Princeton Bancorp, Inc. (NASDAQ:BPRN) Plans Quarterly Dividend of $0.35

Princeton Bancorp, Inc. (NASDAQ:BPRN) announced a quarterly dividend on Wednesday, January 21st. Stockholders of record on Wednesday, February 4th will be given a dividend of 0.35 per share on...

Princeton Bancorp, Inc. Announces Declaration of a $0.35 Quarterly Cash Dividend

Princeton Bancorp, Inc. Announces Declaration of a $0.35 Quarterly Cash Dividend Princeton Bancorp, Inc. Announces Declaration of a $0.35 Quarterly Cash Dividend PR Newswire PRINCETON, N.J., Jan. 21...

Princeton Bancorp (BPRN) to Release Earnings on Tuesday

Princeton Bancorp (NASDAQ:BPRN) will be releasing its Q4 2025 earnings before the market opens on Tuesday, January 27. (View Earnings Report at...

Princeton Bancorp, Inc. (NASDAQ:BPRN) Short Interest Down 30.3% in December

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 37,540 shares, a...

Princeton Bancorp, Inc. operates as a bank holding company. It is a full-service financial institution that provides business and personal banking. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The company was founded in 2017 and is headquartered in Princeton, NJ.

Princeton Bancorp Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

BPRN
Bank of Princeton

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BPRN News

BPRNBank of Princeton